Literature DB >> 16528794

Synthesis, anticonvulsant, and anti-inflammatory activities of some new benzofuran-based heterocycles.

Kamal M Dawood1, Hassan Abdel-Gawad, Mohey Ellithey, Hanan A Mohamed, Bahira Hegazi.   

Abstract

Treatment of 2-bromoacetylbenzofuran (2) with pyridine afforded its corresponding pyridinium bromide 3. The latter salt reacted with some activated alkenes and acetylenes to give the corresponding indolizine derivatives. Treatment of the salt 3 with benzylidenemalononitriles 9 afforded polysubstituted aniline derivatives, however with arylidenecyanothioacetamides 15 it gave the corresponding 4,5-dihydrothiophenes. Bromide 3 also coupled with p-chlorobenzenediazonium salt followed by ammonium acetate to give the corresponding 1,2,4,5-tetrazine derivative. The biological activity of the newly synthesized compounds was examined and some of them were found to possess anticonvulsant and anti-inflammatory activities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528794     DOI: 10.1002/ardp.200500176

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  3 in total

1.  Synthesis of 2-phenylazonaphtho[1,8-ef][1,4]diazepines and 9-(3-arylhydrazono)pyrrolo[1,2-a]perimidines as antitumor agents.

Authors:  Thoraya A Farghaly; Eman M H Abbas; Kamal M Dawood; Tarek B A El-Naggar
Journal:  Molecules       Date:  2014-01-08       Impact factor: 4.411

2.  2-Amino-4,5-dihydrothiophene-3-carbonitriles: A New Synthesis, Quantum Chemical Studies, and Mannich-Type Reactions Leading to New Hexahydrothieno[2,3-d]pyrimidines.

Authors:  Victor V Dotsenko; Alexander V Bespalov; Arthur S Vashurin; Nicolai A Aksenov; Inna V Aksenova; Elena A Chigorina; Sergey G Krivokolysko
Journal:  ACS Omega       Date:  2021-11-19

3.  Facile synthesis of heterocycles via 2-picolinium bromide and antimicrobial activities of the products.

Authors:  Elham S Darwish
Journal:  Molecules       Date:  2008-05-01       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.